BPG is committed to discovery and dissemination of knowledge
Welcome to World Journal of Pharmacology

The World Journal of Pharmacology (WJP) is a leading academic journal devoted to reporting the latest, cutting-edge research progress and findings of basic research and clinical practice in the field of pharmacology.  It was launched on February 9, 2012 and is published trimonthly (4 issues annually) by BPG, the world's leading professional clinical medical journal publishing company.

We encourage pharmacologists worldwide to submit manuscripts to the WJP describing their original basic or clinical research findings that are of high academic value and which report new diagnostic techniques or summarize their treatment experiences.

The usual times related to all publication processes of the WJP are as follows: (1) From manuscript receipt to peer-review: 2-4 weeks; (2) From initial manuscript acceptance, with revisions, to return of the revised manuscript from the authors: 4-5 weeks; (3) From return of the revised manuscript from the authors to final acceptance: 1-2 weeks; (4) From final acceptance to an article in press: 2 days; and (5) From article in press designation to formal release of the electronic version and all online documentation: 2-9 weeks.The WJP’s acceptance rate: 51%. Submit here >>

2016 Published Issues
1
Editors-in-Chief

Geoffrey Burnstock, DSc, FAA, FRCS(Hon), FRS, PhD, Professor

Indexing/Abstracting

There is currently no indexing/abstracting.

Journal Metrics

There is currently no impact factor.

ISSN

2220-3192 (online)

Review
Novel strategies for the treatment of diabetic macular edema  
Hoang M Trinh, Mary Joseph, Kishore Cholkar, Dhananjay Pal, Ashim K Mitra
World J Pharmacol 5(1):1-14. Published online Mar 9, 2016. doi: 10.5497/wjp.v5.i1.1
Non-selective beta-blockers in cirrhosis: Current concepts and controversies  
Neil Rajoriya, Dhiraj Tripathi
World J Pharmacol 5(1):15-31. Published online Mar 9, 2016. doi: 10.5497/wjp.v5.i1.15
Allosteric modulation of cholinergic system: Potential approach to treating cognitive deficits of schizophrenia  
Shaun Hopper, Madhara Udawela, Elizabeth Scarr, Brian Dean
World J Pharmacol 5(1):32-43. Published online Mar 9, 2016. doi: 10.5497/wjp.v5.i1.32
Minireviews
Adalimumab and pharmacokinetics: Impact on the clinical prescription for inflammatory bowel disease  
Anne-Laure Pelletier, Pascale Nicaise-Roland
World J Pharmacol 5(1):44-50. Published online Mar 9, 2016. doi: 10.5497/wjp.v5.i1.44